PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium

Journal of Clinical Investigation

Volumn 110, Issue 6, 2002, Pages 815-825

  Dupont, Joëlle ^a,b   Renou, Jean Pierre ^a   Shani, Moshe ^a   Hennighausen, Lothar ^a   LeRoith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN 5; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENOTYPE; GROWTH RETARDATION; INVOLUTION; LACTATION; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PUBERTY; SURVIVAL;

EID: 0036738462     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0213829     Document Type: Article

References (53)

1. Think globally, act locally: The making of a mouse mammary gland
2. Growth factors in mammary gland function
3. The hormonal control of mammary growth and lactation
4. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development
5. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development
6. IGF and insulin action in the mammary gland: Lessons from transgenic and knockout models
7. Expression ofovine insulin-like growth factor-1 (IGF-1) stimulates alveolar bud development in mammary glands of transgenic mice
8. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression
9. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model
10. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
11. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
12. Tumor suppressor PTEN: Modulator of cell signaling, growth, migration and apoptosis
13. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated prorein (MAP) kinase signaling pathways
14. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas
15. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
16. Effect of PRL on MAPK activation: Negative regulatory role of the C-terminal part of the PRL receptor
17. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation
18. Growth defects induced by perturbation of β1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways
19. MAP kinase pathway signalling is essential for extracellular matrix determined mammary epithelial cell survival
20. Apoptosis in normal and neoplastic mammary gland development
21. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
22. Mammary gland involution is delayed by activated akt in transgenic mice
23. Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B
24. Mechanically induced electrical responses in murine mammary epithelials cells in primary culture
25. Inhibition of IGFBP-5 binding to extracellular matrix and IGF-1 stimulated DNA synthesis by a peptide fragment of IGFBP-5
26. The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland
27. Nutritional state regulates insulin receptor and IRS-1 phosphorylation and expression in chicken
28. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region
29. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast
30. Initiating oncogenic event determines gene-expression patterns of human breast cancer models
31. DNA arrays for analysis of gene expression
32. Signaling pathways in mammary gland development
33. Mammary gland development and tumorigenesis in estrogen receptor knockout mice
34. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities
35. Expression of a whey acidic protein transgene during mammary development. Evidence for different mechanisms of regulation during pregnancy and lacration
36. PTEN and myotubularin: Novel phosphoinositide
37. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
38. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
39. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb2/Sos complex formation in a breast cancer model
40. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
41. Prolactin-PRL receptor system increases cell proliferation involving JNK (c-jun amino terminal kinase) and AP-1 activation: Inhibition by glucocorticoids
42. The high mobility group protein, HMGI-C
43. Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor
44. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model
45. T cell-specific loss of Pten leads to defects in central and peripheral tolerance
46. Impaired Fas response and autoimmunity in Pten+/-mice
47. Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland
48. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I) mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line
49. Upregulation of thymosin bera 10 by Mycobacterium bovis infection of bovine macrophages is associated with apoptosis
50. Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin alpha2-deficient mice
51. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ
52. Roles of Fas and Fas ligand during mammary gland remodeling